The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Acute kidney injury in critically ill patients with COVID-19
Open accessAbstract
Acute kidney injury (AKI) has been reported in up to 25% of critically-ill patients with SARS-CoV-2 infection, especially in those with underlying comorbidities. AKI is associated with high mortality rates in this setting, especially when renal replacement therapy is required. Several studies have highlighted changes in urinary sediment, including proteinuria and hematuria, and evidence of urinary SARS-CoV-2 excretion, suggesting the presence of a renal reservoir for the virus. The pathophysiology of COVID-19 associated AKI could be related to unspecific mechanisms but also to COVID-specific mechanisms such as direct cellular injury resulting from viral entry through the receptor (ACE2) which is highly expressed in the kidney, an imbalanced renin–angotensin–aldosteron system, pro-inflammatory cytokines elicited by the viral infection and thrombotic events. Non-specific mechanisms include haemodynamic alterations, right heart failure, high levels of PEEP in patients requiring mechanical ventilation, hypovolemia, administration of nephrotoxic drugs and nosocomial sepsis. To date, there is no specific treatment for COVID-19 induced AKI. A number of investigational agents are being explored for antiviral/immunomodulatory treatment of COVID-19 and their impact on AKI is still unknown. Indications, timing and modalities of renal replacement therapy currently rely on non-specific data focusing on patients with sepsis. Further studies focusing on AKI in COVID-19 patients are urgently warranted in order to predict the risk of AKI, to identify the exact mechanisms of renal injury and to suggest targeted interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 3×
“found evidence of glomerular ischemia in 3 patients with fibrin thrombi within the glomerular capillary loops [29], likely reflecting coagulation activation in COVID-19 patients [16].”
BackgroundResultHoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 2×
“Second, others mechanisms could contribute to AKI development in patients with acute respiratory distress syndrome (ARDS), which is the leading cause of admission in patients with severe SARS-CoV-2 infection [2, 5, 7].”
BackgroundChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413 · cited 1×
“However, elevation of cytokines is moderate (median IL-6 of 79 pg/ml (39–135 pg/ml) in our ICU cohort (unpublished data)) when compared to hyper-inflammatory ARDS (median IL-6 of 1568 pg/mL; 517-3205 pg/mL) [66], sepsis (median IL-6 of 1346 pg/ mL; 292-8789 pg/mL) [67] or cytokine release syndrome where median interle…”
ResultIncidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06033-2 · Cited by 1,852
Multiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“Interestingly, multiple underlying conditions were associated with SARS-CoV-2 kidney tropism [30].”
BackgroundRenal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Su, H., Yang, M., Wan, C., Yi, L.-X., Tang, F., Zhu, H.-Y., Yi, F., Yang, H.-C., Fogo, A. B., Nie, X., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.003 · Cited by 1,755
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.-Q., Du, P., Wei, D., Zhang, Y., Sun, X.-X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,593
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
Initiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243 · cited 1×
“The timing of RRT, modality (intermittent versus continuous) and dose may therefore rely on non COVID-19 data [74].”
MethodZhang, P., Zhu, L., Cai, J., Lei, F., Qin, J.-J., Xie, J., Liu, Y.-M., Zhao, Y.-C., Huang, X., Lin, L., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317134 · Cited by 1,133
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,073
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,063
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., Tang, C., Sang, L., Liu, J., Ni, Z., et al. (2020) · Chest · doi:10.1016/j.chest.2020.04.010 · Cited by 614
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Hendren, N. S., Drazner, M. H., Bozkurt, B., & Cooper, L. T. (2020) · Circulation · doi:10.1161/circulationaha.120.047349 · Cited by 576
Pan, X.-W., Xu, D., Zhang, H., Zhou, W., Wang, L.-H., & Cui, X.-G. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06026-1 · Cited by 555
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C.-T., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 524
Caution on Kidney Dysfunctions of COVID-19 Patients
Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., Song, S., Li, J., Duan, G., Zhou, Y., Wu, X., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3559601 · Cited by 522
Fontanarosa, P. B., Ranieri, V. M., Giunta, F., Suter, P. M., & Slutsky, A. S. (2000) · JAMA · doi:10.1001/jama.284.1.43 · Cited by 486
Complement as a target in COVID-19?
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 484
Wang, L., Li, X., Chen, H., Yan, S., Li, D., Li, Y., & Gong, Z. (2020) · American Journal of Nephrology · doi:10.1159/000507471 · Cited by 452
Acute kidney injury: what's the prognosis?
Murugan, R., & Kellum, J. A. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.13 · Cited by 429
Single-Cell Profiling Reveals Sex, Lineage, and Regional Diversity in the Mouse Kidney
Ransick, A., Lindström, N. O., Liu, J., Zhu, Q., Guo, J.-J., Alvarado, G. F., Kim, A. D., Black, H. G., Kim, J., & McMahon, A. P. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.10.005 · Cited by 429
de Abajo, F. J., Rodríguez-Martín, S., Lerma, V., Mejía-Abril, G., Aguilar, M., García-Luque, A., Laredo, L., Laosa, O., Centeno-Soto, G. A., Ángeles Gálvez, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31030-8 · Cited by 408
IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury
Nechemia-Arbely, Y., Barkan, D., Pizov, G., Shriki, A., Rose-John, S., Galun, E., & Axelrod, J. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070744 · Cited by 400
Chen, D., Li, X., Song, Q., Hu, C., Su, F., Dai, J., Ye, Y., Huang, J., & Zhang, X. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.11122 · Cited by 398
Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration
Lerolle, N., Nochy, D., Guérot, E., Bruneval, P., Fagon, J.-Y., Diehl, J.-L., & Hill, G. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1723-x · Cited by 370
Acute Renal Failure in Endotoxemia Is Caused by TNF Acting Directly on TNF Receptor-1 in Kidney
Cunningham, P. N., Dyanov, H. M., Park, P., Wang, J., Newell, K. A., & Quigg, R. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5817 · Cited by 359
Yang, G., Tan, Z., Zhou, L., Yang, M., Peng, L., Liu, J., Cai, J., Yang, R., Han, J., Huang, Y., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15143 · Cited by 342
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
Jin, M., & Tong, Q. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200445 · Cited by 338
Collapsing Glomerulopathy in a Patient With COVID-19
Larsen, C. P., Bourne, T. D., Wilson, J. D., Saqqa, O., & Sharshir, M. A. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.04.002 · Cited by 314
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Vuille-dit-Bille, R. N., Camargo, S. M., Emmenegger, L., Sasse, T., Kummer, E., Jando, J., Hamie, Q. M., Meier, C. F., Hunziker, S., Forras-Kaufmann, Z., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1889-6 · Cited by 312
Sinha, P., Delucchi, K. L., McAuley, D. F., O'Kane, C. M., Matthay, M. A., & Calfee, C. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30369-8 · Cited by 307
Lung–Kidney Cross-Talk in the Critically Ill Patient
Husain-Syed, F., Slutsky, A. S., & Ronco, C. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0420cp · Cited by 301
van den Akker, J. P., Egal, M., & Groeneveld, A. J. (2013) · Critical Care · doi:10.1186/cc12743 · Cited by 297
Collapsing glomerulopathy in a COVID-19 patient
Kissling, S., Rotman, S., Gerber, C., Halfon, M., Lamoth, F., Comte, D., Lhopitallier, L., Sadallah, S., & Fakhouri, F. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.006 · Cited by 294
Joannidis, M., Forni, L. G., Klein, S. J., Honore, P. M., Kashani, K., Ostermann, M., Prowle, J., Bagshaw, S. M., Cantaluppi, V., Darmon, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05869-7 · Cited by 271
Self-citationDeshotels, M. R., Xia, H., Sriramula, S., Lazartigues, E., & Filipeanu, C. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03743 · Cited by 264
Is the kidney a target of SARS-CoV-2?
Martinez-Rojas, M. A., Vega-Vega, O., & Bobadilla, N. A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2020 · Cited by 237
Interleukin-6 Causes Endothelial Barrier Dysfunction via the Protein Kinase C Pathway
Desai, T. R., Leeper, N. J., Hynes, K. L., & Gewertz, B. L. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6415 · Cited by 235
Factors associated with acute kidney injury in acute respiratory distress syndrome
Panitchote, A., Mehkri, O., Hastings, A., Hanane, T., Demirjian, S., Torbic, H., Mireles-Cabodevila, E., Krishnan, S., & Duggal, A. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0552-5 · Cited by 210
Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China
Cao, M., Zhang, D., Wang, Y., Lu, Y., Zhu, X., Li, Y., Xue, H., Lin, Y., Zhang, M., Sun, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20030395 · Cited by 199
ACE and ACE2 in kidney disease
Mizuiri, S. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i1.74 · Cited by 187
Bellomo, R., Ronco, C., Mehta, R. L., Asfar, P., Boisramé-Helms, J., Darmon, M., Diehl, J.-L., Duranteau, J., Hoste, E. A. J., Olivier, J.-B., et al. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0260-y · Cited by 172
Self-citationCoronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum
Ronco, C., Reis, T. D. A., & Rosa, S. D. (2020) · Blood Purification · doi:10.1159/000507039 · Cited by 127
The Role of the Complement System in Acute Kidney Injury
McCullough, J. W., Renner, B., & Thurman, J. M. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.005 · Cited by 112
Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation
Darmon, M., Schortgen, F., Rusel, L., Moutereau, S., Mayaux, J., Marco, F. D., Devaquet, J., Brun‐Buisson, C., & Brochard, L. J. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1372-5 · Cited by 106
Self-citationMisapplications of Commonly Used Kidney Equations
Nguyen, M. T. P., Maynard, S. E., & Kimmel, P. L. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05731108 · Cited by 62
Shen, X., Fu, L., Fei, J., Xiang, H.-X., Xiang, Y., Tan, Z.-X., Li, M., Liu, F., Li, Y., Han, M., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042408 · Cited by 60
Right Ventricular Function, Peripheral Edema, and Acute Kidney Injury in Critical Illness
Chen, C., Lee, J., Johnson, A. E. W., Mark, R. G., Celi, L. A., & Danziger, J. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.05.017 · Cited by 47
Cyclophilin A and CD147 associate with progression of diabetic nephropathy
Chiu, P., Su, S., Tsai, C., Wu, C., Kuo, C., Kor, C., Chang, C., & Liu, C. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1523545 · Cited by 26
Cited by
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06294-x · Cited by 924
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
COVID-19: Discovery, diagnostics and drug development
Asselah, T., Durantel, D., Pasmant, E., Lau, G., & Schinazi, R. F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.031 · Cited by 437
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Grasselli, G., Scaravilli, V., Mangioni, D., Scudeller, L., Alagna, L., Bartoletti, M., Bellani, G., Biagioni, E., Bonfanti, P., Bottino, N., et al. (2021) · Chest · doi:10.1016/j.chest.2021.04.002 · Cited by 374
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
Li, X., Zhong, X., Wang, Y., Zeng, X., Luo, T., & Liu, Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250602 · Cited by 236
Metadata
- Authors
- Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L.
- Venue
- Intensive Care Medicine
- Published
- 2020-06-12
- Volume
- 46
- Issue
- 7
- Pages
- 1339-1348
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W3034521516
- Cited by
- 529
- References
- 70
- FWCI
- 65.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.